FR2601675B1
(fr)
|
1986-07-17 |
1988-09-23 |
Rhone Poulenc Sante |
Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
|
JPS6328743A
(ja)
|
1986-07-23 |
1988-02-06 |
Oi Seisakusho Co Ltd |
自動車用シ−トスライド装置
|
US5580575A
(en)
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
US5407683A
(en)
|
1990-06-01 |
1995-04-18 |
Research Corporation Technologies, Inc. |
Pharmaceutical solutions and emulsions containing taxol
|
JPH04164024A
(ja)
|
1990-10-29 |
1992-06-09 |
Sankyo Co Ltd |
医薬物質含有自己乳化型脂肪乳剤組成物の製造方法
|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
US5698582A
(en)
|
1991-07-08 |
1997-12-16 |
Rhone-Poulenc Rorer S.A. |
Compositions containing taxane derivatives
|
FR2678833B1
(fr)
|
1991-07-08 |
1995-04-07 |
Rhone Poulenc Rorer Sa |
Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
|
US5750561A
(en)
|
1991-07-08 |
1998-05-12 |
Rhone-Poulenc Rorer, S.A. |
Compositions containing taxane derivatives
|
US5714512A
(en)
|
1991-07-08 |
1998-02-03 |
Rhone-Poulenc Rorer, S.A. |
Compositions containing taxane derivatives
|
DE4208527A1
(de)
|
1992-03-17 |
1993-09-23 |
Max Planck Gesellschaft |
Liposomen mit negativer ueberschussladung
|
FR2691460B1
(fr)
|
1992-05-21 |
1994-07-22 |
Rhone Poulenc Rorer Sa |
Nouveaux derives du taxane, leur preparation et les compositions qui les contiennent.
|
US5602112A
(en)
|
1992-06-19 |
1997-02-11 |
Supergen, Inc. |
Pharmaceutical formulation
|
PT835657E
(pt)
|
1992-11-27 |
2004-11-30 |
Mayne Pharma Usa Inc |
Composicao injectavel estavel de paclitaxel
|
FR2698543B1
(fr)
|
1992-12-02 |
1994-12-30 |
Rhone Poulenc Rorer Sa |
Nouvelles compositions à base de taxoides.
|
FR2698871B1
(fr)
|
1992-12-09 |
1995-02-24 |
Rhone Poulenc Rorer Sa |
Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
|
US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
EP0693924B2
(en)
|
1993-02-22 |
2008-04-09 |
Abraxis BioScience, Inc. |
Methods for (in vivo) delivery of biologics and compositions useful therefor
|
US20030133955A1
(en)
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US5885486A
(en)
|
1993-03-05 |
1999-03-23 |
Pharmaciaand Upjohn Ab |
Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
|
US5785976A
(en)
|
1993-03-05 |
1998-07-28 |
Pharmacia & Upjohn Ab |
Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
|
CA2091152C
(en)
|
1993-03-05 |
2005-05-03 |
Kirsten Westesen |
Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
|
FR2703049B1
(fr)
|
1993-03-22 |
1995-04-21 |
Rhone Poulenc Rorer Sa |
Procédé de purification des taxoïdes.
|
JP3526887B2
(ja)
|
1993-04-23 |
2004-05-17 |
帝國製薬株式会社 |
消炎鎮痛外用貼付剤
|
US5415869A
(en)
|
1993-11-12 |
1995-05-16 |
The Research Foundation Of State University Of New York |
Taxol formulation
|
ATE220894T1
(de)
|
1993-12-29 |
2002-08-15 |
Matrix Pharma |
Zusammensetzung für lokale freigabe von zytostatika
|
US5925669A
(en)
|
1994-03-22 |
1999-07-20 |
Molecular/Structural Bio Technologies, Inc. |
Carrier compositions for anti-neoplastic drugs
|
FR2722191B1
(fr)
|
1994-07-08 |
1996-08-23 |
Rhone Poulenc Rorer Sa |
Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
|
US5616330A
(en)
|
1994-07-19 |
1997-04-01 |
Hemagen/Pfc |
Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
|
DE4430593C2
(de)
|
1994-08-20 |
1999-01-14 |
Max Delbrueck Centrum |
Verfahren zur Herstellung von Liposomal verkapseltem Taxol
|
DE4440337A1
(de)
|
1994-11-11 |
1996-05-15 |
Dds Drug Delivery Services Ges |
Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
|
US5789000A
(en)
|
1994-11-14 |
1998-08-04 |
Bionumerik Pharmaceuticals, Inc. |
Sterile aqueous parenteral formulations of cis-diammine dichloro platinum
|
US5580899A
(en)
|
1995-01-09 |
1996-12-03 |
The Liposome Company, Inc. |
Hydrophobic taxane derivatives
|
US5716928A
(en)
|
1995-06-07 |
1998-02-10 |
Avmax, Inc. |
Use of essential oils to increase bioavailability of oral pharmaceutical compounds
|
EP0760237A1
(en)
|
1995-08-30 |
1997-03-05 |
Cipla Limited |
Oil-in-water microemulsions
|
US5968972A
(en)
|
1995-10-26 |
1999-10-19 |
Baker Norton Pharmaceuticals, Inc. |
Method for increasing the oral bioactivity of pharmaceutical agents
|
US6964946B1
(en)
|
1995-10-26 |
2005-11-15 |
Baker Norton Pharmaceuticals, Inc. |
Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
|
US6245805B1
(en)
|
1995-10-26 |
2001-06-12 |
Baker Norton Pharmaceuticals, Inc. |
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
|
EP0876145A4
(en)
*
|
1995-12-21 |
1999-04-21 |
Genelabs Tech Inc |
TAX COMPOSITION AND PROCEDURE
|
KR100330373B1
(ko)
|
1996-05-28 |
2002-11-07 |
주식회사한국신약 |
탁솔을 함유한 주사용 약제 조성물
|
US5877205A
(en)
|
1996-06-28 |
1999-03-02 |
Board Of Regents, The University Of Texas System |
Parenteral paclitaxel in a stable non-toxic formulation
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
US6727280B2
(en)
|
1997-01-07 |
2004-04-27 |
Sonus Pharmaceuticals, Inc. |
Method for treating colorectal carcinoma using a taxane/tocopherol formulation
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
US6121245A
(en)
|
1997-01-29 |
2000-09-19 |
Firshein; Richard N. |
Method of treating cancer using alkylglycerols in conjunction with chemotherapy
|
WO1998042330A1
(en)
|
1997-03-27 |
1998-10-01 |
Baker Norton Pharmaceuticals, Inc. |
Methods and compositions for treatment of ovarian cancer
|
EP1023050B1
(en)
|
1997-06-27 |
2013-09-25 |
Abraxis BioScience, LLC |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
CA2211949A1
(en)
|
1997-07-21 |
1999-01-29 |
David Farley Johnson |
Nonaqueous compositions for parenteral administration
|
AU728695B2
(en)
|
1997-07-29 |
2001-01-18 |
Boehringer Ingelheim International Gmbh |
Self-emulsifying formulation for lipophilic compounds
|
JP4524367B2
(ja)
|
1997-07-29 |
2010-08-18 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
自己乳化性処方形態の酸性親油性化合物用の医薬組成物
|
US6281175B1
(en)
|
1997-09-23 |
2001-08-28 |
Scimed Life Systems, Inc. |
Medical emulsion for lubrication and delivery of drugs
|
US6090407A
(en)
|
1997-09-23 |
2000-07-18 |
Research Development Foundation |
Small particle liposome aerosols for delivery of anti-cancer drugs
|
WO1999029316A1
(en)
|
1997-12-10 |
1999-06-17 |
Severson, Mary, L. |
Pharmaceutical compositions containing an omega-3 fatty acid oil
|
AU2845599A
(en)
|
1998-03-05 |
1999-09-20 |
Phares Pharmaceutical Research N.V. |
Pharmaceutical compositions and their use
|
IL131217A0
(en)
|
1998-03-10 |
2001-01-28 |
Napro Biotherapeutics Inc |
Novel methods and compositions for delivery of taxanes
|
CA2326485C
(en)
*
|
1998-04-01 |
2008-12-09 |
Rtp Pharma Inc. |
Anticancer compositions
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
CA2331640A1
(en)
|
1998-05-07 |
1999-11-11 |
Elan Corporation Plc |
Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
|
EA200001109A1
(ru)
|
1998-05-20 |
2001-06-25 |
ДЗЕ ЛИПОСОМ КОМПАНИ, Инк. |
Новые частицы, композиция на их основе и способ лечения с их применением
|
US7030155B2
(en)
|
1998-06-05 |
2006-04-18 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
US6017948A
(en)
|
1998-10-30 |
2000-01-25 |
Supergen, Inc. |
Water-miscible pharmaceutical compositions
|
US6071952A
(en)
|
1998-12-02 |
2000-06-06 |
Mylan Pharmaceuticals, Inc. |
Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
|
MXPA01005884A
(es)
|
1998-12-11 |
2002-04-24 |
Pharmasolutions Inc |
Composiciones auto-emulsionantes para medicamentos escasamente solubles en agua.
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
US6537585B1
(en)
|
1999-03-26 |
2003-03-25 |
Guilford Pharmaceuticals, Inc. |
Methods and compositions for treating solid tumors
|
EP1171117A4
(en)
|
1999-04-22 |
2002-08-07 |
American Bioscience Inc |
LONG-TERM ADMINISTRATION OF PHARMACOLOGICALLY ACTIVE AGENTS
|
AU5273200A
(en)
*
|
1999-05-24 |
2000-12-12 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
EP1479382A1
(en)
|
1999-06-18 |
2004-11-24 |
IVAX Research, Inc. |
Oral pharmaceutical compositions containing taxanes and methods for treatment employing the same
|
TW422706B
(en)
|
1999-07-01 |
2001-02-21 |
Wang Iz Rung |
An oil-in-water emulsion type of paclitaxel
|
GB9920548D0
(en)
|
1999-08-31 |
1999-11-03 |
Rhone Poulenc Rorer Sa |
Treatment of hepatocellular carcinoma
|
ES2241663T3
(es)
|
1999-09-21 |
2005-11-01 |
Skyepharma Canada Inc. |
Composiciones particuladas modificadas superficialmente de substancias biologicamente activas.
|
WO2001025223A1
(en)
|
1999-10-06 |
2001-04-12 |
The Research Foundation Of State University Of New York |
Stabilization of taxane-containing dispersed systems
|
US6720001B2
(en)
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
US6828346B2
(en)
|
1999-10-25 |
2004-12-07 |
Supergen, Inc. |
Methods for administration of paclitaxel
|
US6136846A
(en)
|
1999-10-25 |
2000-10-24 |
Supergen, Inc. |
Formulation for paclitaxel
|
EP1225956A1
(en)
|
1999-10-27 |
2002-07-31 |
Baker Norton Pharmaceuticals, Inc. |
Method and compositions for administering taxanes orally to human patients
|
US7919113B2
(en)
|
1999-12-30 |
2011-04-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Dispersible concentrate lipospheres for delivery of active agents
|
CA2367661A1
(en)
|
2000-02-02 |
2001-08-09 |
Robert A. Holton |
Taxane formulations having improved solubility
|
KR20030019327A
(ko)
|
2000-03-24 |
2003-03-06 |
아이박스 리서치 인코포레이티드 |
탁산-기저 조성물을 안정시키는 금속염의 용도
|
JP3448006B2
(ja)
|
2000-03-29 |
2003-09-16 |
独立行政法人食品総合研究所 |
機能性エマルション
|
GB0008785D0
(en)
|
2000-04-10 |
2000-05-31 |
Novartis Ag |
Organic compounds
|
US6761901B1
(en)
|
2000-05-02 |
2004-07-13 |
Enzrel Inc. |
Liposome drug delivery
|
EP1278512A2
(en)
|
2000-05-03 |
2003-01-29 |
MBT Munich Biotechnology AG |
Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites
|
DE10036871A1
(de)
|
2000-07-28 |
2002-02-14 |
Pharmasol Gmbh |
Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
|
US20020141966A1
(en)
|
2000-11-16 |
2002-10-03 |
Wenbin Dang |
Compositions for treatment of malignant effusions, and methods of making and using the same
|
ATE365536T1
(de)
|
2000-11-29 |
2007-07-15 |
Lyotropic Therapeutics Inc |
Lösungsmittelsysteme für pharmazeutische mittel
|
US20030099674A1
(en)
|
2001-08-11 |
2003-05-29 |
Chen Andrew X. |
Lyophilized injectable formulations containing paclitaxel or other taxoid drugs
|
AU2002357012A1
(en)
*
|
2001-11-27 |
2003-06-10 |
Transform Pharmaceuticals, Inc. |
Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
|
US6815642B2
(en)
|
2001-12-19 |
2004-11-09 |
Delphi Technologies, Inc. |
Apparatus and method for heating a steering wheel
|
WO2003099264A1
(en)
|
2002-05-23 |
2003-12-04 |
Umd, Inc. |
Compositions and method for transmucosal drug delivery and cryoprotection
|
US7935704B2
(en)
|
2003-08-01 |
2011-05-03 |
Nereus Pharmaceuticals, Inc. |
Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
|
US7919497B2
(en)
|
2002-08-02 |
2011-04-05 |
Nereus Pharmaceuticals, Inc. |
Analogs of dehydrophenylahistins and their therapeutic use
|
ATE374767T1
(de)
|
2002-08-02 |
2007-10-15 |
Nereus Pharmaceuticals Inc |
Dehydrophenylahistine und analoge davon sowie ein verfahren zur herstellung von dehydrophenylahistinen und analogen davon
|
US7387623B2
(en)
|
2002-08-21 |
2008-06-17 |
Pfizer Inc. |
Injectable pharmaceutical suspension in a two-chamber vial
|
CA2500908A1
(en)
|
2002-10-04 |
2004-04-22 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
US20080220074A1
(en)
|
2002-10-04 |
2008-09-11 |
Elan Corporation Plc |
Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
|
EP1569620A4
(en)
|
2002-10-30 |
2006-03-22 |
Spherics Inc |
NANOPARTICULAR BIOACTIVE AGENTS
|
US20040122081A1
(en)
|
2002-11-08 |
2004-06-24 |
Gogate Uday Shankar |
Pharmaceutical compositions and methods of using taxane derivatives
|
US6838569B2
(en)
|
2002-12-16 |
2005-01-04 |
Dabur India Limited |
Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
|
AU2003303513A1
(en)
|
2002-12-30 |
2004-07-29 |
Angiotech International Ag |
Tissue reactive compounds and compositions and uses thereof
|
US8703982B2
(en)
|
2003-03-17 |
2014-04-22 |
Phyton Holdings Llc |
Purification of taxanes
|
JP2007504273A
(ja)
|
2003-05-30 |
2007-03-01 |
エーアールシー ファーマシューティカルズ,インク. |
種々の作用剤を用いた、線維性癒着の抑制に関する医薬組成物及び方法
|
EP1498143A1
(en)
|
2003-07-18 |
2005-01-19 |
Aventis Pharma S.A. |
Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
|
EP1498120A1
(en)
|
2003-07-18 |
2005-01-19 |
Aventis Pharma S.A. |
Semi-solid formulations for the oral administration of taxoids
|
US20060292186A1
(en)
|
2003-08-29 |
2006-12-28 |
Novagali Pharma Sa |
Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
|
WO2005061474A1
(en)
|
2003-12-12 |
2005-07-07 |
Quiral Química Do Brasil |
Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions
|
US7345093B2
(en)
|
2004-04-27 |
2008-03-18 |
Formatech, Inc. |
Methods of enhancing solubility of compounds
|
US20060052951A1
(en)
|
2004-05-07 |
2006-03-09 |
Yaffe Michael B |
Methods and compositions for cancer treatment relating to BRCA1 BRCT domain recognition of phosphorylated BACH1
|
US8557861B2
(en)
|
2004-09-28 |
2013-10-15 |
Mast Therapeutics, Inc. |
Low oil emulsion compositions for delivering taxoids and other insoluble drugs
|
US7446126B2
(en)
|
2004-10-08 |
2008-11-04 |
Indena S.P.A. |
Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
|
US20080064760A1
(en)
|
2004-10-29 |
2008-03-13 |
Ping Li |
Spontaneously Dispersible Pharmaceutical Composition
|
JP4734910B2
(ja)
|
2004-12-09 |
2011-07-27 |
日油株式会社 |
難水溶性薬剤用可溶化剤組成物
|
CA2598441A1
(en)
|
2005-02-24 |
2006-08-31 |
Elan Pharma International Limited |
Nanoparticulate formulations of docetaxel and analogues thereof
|
ITMI20050614A1
(it)
|
2005-04-12 |
2006-10-13 |
Indena Spa |
Processo per la purificazione della 10-deacetilbaccatina iii dalla 10-deacetil-2-debenzoil-2-pentenoilbaccatina iii
|
CA2611592A1
(en)
|
2005-06-17 |
2006-12-21 |
Hospira Australia Pty Ltd |
Liquid pharmaceutical formulations of docetaxel
|
DE102005039579B4
(de)
|
2005-08-19 |
2022-06-30 |
Magforce Ag |
Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen
|
US8034765B2
(en)
*
|
2005-08-31 |
2011-10-11 |
Abraxis Bioscience, Llc |
Compositions and methods for preparation of poorly water soluble drugs with increased stability
|
CN101291659A
(zh)
|
2005-08-31 |
2008-10-22 |
阿布拉科斯生物科学有限公司 |
包含水难溶性药剂和抗微生物剂的组合物
|
US20070142457A1
(en)
|
2005-10-12 |
2007-06-21 |
Alessandro Pontiroli |
Crystalline forms of docetaxel and processes for their preparation
|
US20100166872A1
(en)
|
2005-10-21 |
2010-07-01 |
Amarjit Singh |
Novel improved compositions for cancer therapy
|
AR056815A1
(es)
|
2005-11-18 |
2007-10-24 |
Synthon Bv |
PROCESO PARA PREPARAR MONTELUKAST, INTERMEDIARIOS DEL MISMO Y SUS SALES DE ADICIoN Y PROCEDIMIENTO DE PURIFICACIoN DE ÉSTOS Y DE MONTELUKAST
|
CZ300305B6
(cs)
|
2005-12-20 |
2009-04-15 |
Heaton, A. S. |
Farmaceutická kompozice obsahující derivát taxanu se zlepšenou terapeutickou úcinností
|
MX2008008119A
(es)
|
2005-12-21 |
2008-09-24 |
Tapestry Pharmaceuticals Inc |
Procesos para derivados de taxano y compuestos intermedios utiles en los mismos.
|
CA2634453A1
(en)
|
2005-12-21 |
2007-06-28 |
Tapestry Pharmaceuticals, Inc. |
Novel compounds and methods for forming taxanes and using the same
|
KR100995390B1
(ko)
|
2006-01-02 |
2010-11-19 |
주식회사 삼양제넥스 |
무정형, 무수결정형 또는 수화 결정형 도세탁셀의 제조방법
|
EP1808173A1
(en)
|
2006-01-12 |
2007-07-18 |
Matthias Dormeyer |
Use of CNS penetrating anticancer compounds for the treatment of protozan diseases
|
BRPI0600285C1
(pt)
|
2006-01-13 |
2011-10-11 |
Brz Biotecnologia Ltda |
compostos farmacêuticos contendo nanopartìculas úteis para tratamento de lesões reestenóticas
|
AR054215A1
(es)
|
2006-01-20 |
2007-06-13 |
Eriochem Sa |
Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
|
JP5403585B2
(ja)
|
2006-01-23 |
2014-01-29 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム |
活性薬剤用のデリバリーシステム
|
BRPI0600194A
(pt)
*
|
2006-01-30 |
2007-10-23 |
Quiral Quimica Do Brasil S A |
composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas
|
CN101023940A
(zh)
|
2006-02-20 |
2007-08-29 |
郝守祝 |
一种紫杉烷类化合物的药用组合物、制备方法及用途
|
EP1998808A1
(en)
|
2006-02-21 |
2008-12-10 |
Dabur Pharma Limited |
Stable pharmaceutical composition of taxanes
|
AU2007224006A1
(en)
|
2006-03-07 |
2007-09-13 |
Novavax, Inc. |
Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same
|
KR20080100264A
(ko)
|
2006-03-21 |
2008-11-14 |
닥터 레디스 레보러터리즈 리미티드 |
도세탁셀의 다형체와 그 제조방법
|
US20090306400A1
(en)
|
2006-03-27 |
2009-12-10 |
Henri John T |
Convergent process for the synthesis of taxane derivatives.
|
MX2008012794A
(es)
|
2006-04-03 |
2008-10-15 |
Teva Pharma |
Microparticulas de farmacos.
|
AU2007246077A1
(en)
|
2006-05-03 |
2007-11-08 |
I.Q.A., A.S. |
Pharmaceutical composition containing taxane derivative destined for the preparation of an infusion solution, method of preparation thereof and use thereof
|
KR100917809B1
(ko)
|
2006-05-22 |
2009-09-18 |
에스케이케미칼주식회사 |
우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물
|
CN1857222B
(zh)
|
2006-06-05 |
2010-05-12 |
中国医药研究开发中心有限公司 |
多西紫杉醇静脉注射亚微乳剂及其制备方法
|
US20110159111A1
(en)
|
2006-06-29 |
2011-06-30 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
US20100034749A1
(en)
|
2006-07-10 |
2010-02-11 |
Medigene Ag |
Use of a Cationic Collodal Preparation for the Diagnosis and Treatment of Ocular Diseases
|
US8728527B2
(en)
|
2006-07-24 |
2014-05-20 |
Luminus Biosciences, Inc. |
Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
|
WO2008026048A2
(en)
|
2006-08-31 |
2008-03-06 |
Wockhardt Research Centre |
Stable injectable pharmaceutical compositions of docetaxel
|
EP2330101A1
(en)
|
2006-10-20 |
2011-06-08 |
Scinopharm Singapore Pte, Ltd. |
Process for making crystalline docetaxel
|
WO2008052766A2
(en)
|
2006-11-03 |
2008-05-08 |
Medigene Ag |
Cationic colloidal carriers for delivery of active agents to the blood-brain barrier in the course of neuroinflammatory diseases
|
CN100998560A
(zh)
|
2006-12-27 |
2007-07-18 |
沈阳药科大学 |
多烯紫杉醇冻干乳剂及其制备方法
|
EP1946747A1
(en)
|
2007-01-17 |
2008-07-23 |
Sandoz AG |
Pharmaceutical composition of improved stability containing taxane derivatives
|
CN101244053B
(zh)
*
|
2007-02-16 |
2010-12-08 |
石药集团中奇制药技术(石家庄)有限公司 |
以多西他赛为主组分的新的分散体系
|
WO2008102374A1
(en)
|
2007-02-20 |
2008-08-28 |
Dabur Pharma Limited |
Amorphous form of docetaxel
|
AU2008227852B2
(en)
|
2007-03-19 |
2011-02-24 |
Fresenius Kabi Oncology Ltd. |
Proliposomal and liposomal compositions
|
KR100878455B1
(ko)
|
2007-04-10 |
2009-01-13 |
한미약품 주식회사 |
안정한 무수결정형 도세탁셀 및 이의 제조방법
|
CN102014918A
(zh)
|
2007-04-20 |
2011-04-13 |
太阳医药工业有限公司 |
由微量沉淀产生的药学组合物
|
FR2917088B1
(fr)
|
2007-06-08 |
2009-09-04 |
Aventis Pharma Sa |
Dissolution directe du docetaxel dans un solvant dans le polysorbate 80
|
JP2010530872A
(ja)
|
2007-06-22 |
2010-09-16 |
サイドース・エルエルシー |
Tween80を含まないドセタキセル可溶化製剤
|
US20100197944A1
(en)
|
2007-07-04 |
2010-08-05 |
Dr. Reddy's Laboratories Limited |
Docetaxel process and polymorphs
|
CN101396354B
(zh)
|
2007-09-30 |
2010-12-01 |
江苏恒瑞医药股份有限公司 |
一种稳定的塔三烷类化合物液体组合物及其制备方法和其应用
|
EP2205215A2
(en)
|
2007-10-01 |
2010-07-14 |
Intas Pharmaceuticals Limited |
Docetaxel injectable composition, being absolutely free of ethanol
|
FR2922107B1
(fr)
|
2007-10-10 |
2010-02-26 |
Aventis Pharma Sa |
Nouvelles compositions a base de taxoides
|
JP2011500773A
(ja)
|
2007-10-23 |
2011-01-06 |
アンティソーマ・リサーチ・リミテッド |
Dmxaaナトリウム塩の結晶形態
|
US20090130198A1
(en)
|
2007-11-21 |
2009-05-21 |
Innopharmax Inc. |
Pharmaceutical composition with enhanced bioavailability
|
ES2509490T3
(es)
*
|
2007-12-24 |
2014-10-17 |
Sun Pharma Advanced Research Company Limited |
Nanodispersión
|
KR101053780B1
(ko)
|
2008-02-29 |
2011-08-02 |
동아제약주식회사 |
도세탁셀을 함유하는 단일액상의 안정한 약제학적 조성물
|
CN101525321B
(zh)
|
2008-03-06 |
2012-03-07 |
上海希迪制药有限公司 |
多烯紫杉醇倍半水结晶体及其制备方法
|
EP2265618A2
(en)
|
2008-03-14 |
2010-12-29 |
Sunesis Pharmaceuticals, Inc. |
Aurora kinase inhibitors
|
WO2009121069A2
(en)
|
2008-03-28 |
2009-10-01 |
University Of Massachusetts |
Compositions and methods for the preparation of nanoemulsions
|
EP2262369A4
(en)
|
2008-04-04 |
2013-05-29 |
Robert Shorr |
LIPID-OIL-WATER-NANOEMULSION-DELIVERY SYSTEM FOR ACTIVE SUBSTANCES WITH MICROTUBULI INTERACTION
|
MX355683B
(es)
|
2008-04-18 |
2018-04-26 |
Angiochem Inc |
Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel, y métodos relacionados de preparación y uso.
|
MX2011000795A
(es)
|
2008-07-23 |
2011-03-29 |
Bharat Serums & Vaccines Ltd |
Nanoemulsion estable inyectable de docetaxel de aceite en agua.
|
KR20100018741A
(ko)
*
|
2008-08-07 |
2010-02-18 |
신풍제약주식회사 |
도세탁셀 함유 항암용 주사제 조성물
|
ES2344674B1
(es)
|
2008-08-07 |
2011-06-29 |
Gp Pharm, S.A. |
Composicion farmaceutica inyectable de taxanos.
|
CN101366697A
(zh)
*
|
2008-08-14 |
2009-02-18 |
沈阳万爱普利德医药科技有限公司 |
一种新的包含紫杉醇类物质的注射用纳米脂质载体及其制备方法
|
WO2010023321A1
(en)
|
2008-09-01 |
2010-03-04 |
Stragen Pharma S.A. |
Liquid formulation containing a taxane derivative
|
WO2010033771A2
(en)
|
2008-09-19 |
2010-03-25 |
Trustees Of The University Of Pennsylvania |
Modulators of hsp70/dnak function and methods of use thereof
|
EP2172193A1
(en)
|
2008-10-02 |
2010-04-07 |
Capsulution Nanoscience AG |
Improved nanoparticulate compositions of poorly soluble compounds
|
WO2010045292A2
(en)
*
|
2008-10-15 |
2010-04-22 |
The University Of North Carolina At Chapel Hill |
Nanoparticle compositions comprising liquid oil cores
|
US9050317B2
(en)
|
2008-10-31 |
2015-06-09 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8545857B2
(en)
|
2008-10-31 |
2013-10-01 |
The Invention Science Fund I, Llc |
Compositions and methods for administering compartmentalized frozen particles
|
US8731841B2
(en)
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8603495B2
(en)
|
2008-10-31 |
2013-12-10 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
US9056047B2
(en)
|
2008-10-31 |
2015-06-16 |
The Invention Science Fund I, Llc |
Compositions and methods for delivery of frozen particle adhesives
|
US8409376B2
(en)
|
2008-10-31 |
2013-04-02 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8545806B2
(en)
|
2008-10-31 |
2013-10-01 |
The Invention Science Fund I, Llc |
Compositions and methods for biological remodeling with frozen particle compositions
|
US20100111831A1
(en)
|
2008-10-31 |
2010-05-06 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Compositions and methods for surface abrasion with frozen particles
|
US8731840B2
(en)
|
2008-10-31 |
2014-05-20 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9060926B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US8256233B2
(en)
|
2008-10-31 |
2012-09-04 |
The Invention Science Fund I, Llc |
Systems, devices, and methods for making or administering frozen particles
|
US20100111841A1
(en)
|
2008-10-31 |
2010-05-06 |
Searete Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8788211B2
(en)
|
2008-10-31 |
2014-07-22 |
The Invention Science Fund I, Llc |
Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
|
US8725420B2
(en)
|
2008-10-31 |
2014-05-13 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US8551506B2
(en)
|
2008-10-31 |
2013-10-08 |
The Invention Science Fund I, Llc |
Compositions and methods for administering compartmentalized frozen particles
|
US9072799B2
(en)
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for surface abrasion with frozen particles
|
US9072688B2
(en)
|
2008-10-31 |
2015-07-07 |
The Invention Science Fund I, Llc |
Compositions and methods for therapeutic delivery with frozen particles
|
US9060931B2
(en)
|
2008-10-31 |
2015-06-23 |
The Invention Science Fund I, Llc |
Compositions and methods for delivery of frozen particle adhesives
|
US8762067B2
(en)
|
2008-10-31 |
2014-06-24 |
The Invention Science Fund I, Llc |
Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
|
US8784385B2
(en)
|
2008-10-31 |
2014-07-22 |
The Invention Science Fund I, Llc |
Frozen piercing implements and methods for piercing a substrate
|
WO2010059916A2
(en)
|
2008-11-20 |
2010-05-27 |
Dr. Reddy's Laboratories Ltd. |
Preparation of docetaxel
|
KR101093720B1
(ko)
*
|
2009-03-06 |
2011-12-19 |
지웅길 |
주사제용 항암제 조성물
|
CA3056405C
(en)
|
2009-05-04 |
2021-11-09 |
Bengurion University Of The Negev Research And De |
Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
|
JP5497336B2
(ja)
|
2009-05-20 |
2014-05-21 |
テクノガード株式会社 |
薬物を保持した脂肪粒子を含む非水系組成物およびその製造方法
|
KR101074936B1
(ko)
*
|
2009-05-25 |
2011-10-18 |
보령제약 주식회사 |
도세탁셀 주사제용 조성물 및 그의 제조방법
|
PL388144A1
(pl)
|
2009-05-29 |
2010-12-06 |
Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością |
Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
|
EP2442805A4
(en)
*
|
2009-06-19 |
2012-11-21 |
Sun Pharma Advanced Res Co Ltd |
NANODISPERSION OF A MEDICINE AND METHOD FOR PREPARING THE SAME
|
US8877746B2
(en)
|
2009-08-25 |
2014-11-04 |
Cardioklne, Inc |
Compositions for delivery of insoluble agents
|
CN102038635A
(zh)
|
2009-10-23 |
2011-05-04 |
天津天士力集团有限公司 |
一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法
|
ES2621613T3
(es)
|
2009-11-04 |
2017-07-04 |
Emcure Pharmaceuticals Limited |
Un proceso mejorado para la preparación de derivados de taxano
|
KR101149600B1
(ko)
|
2009-12-31 |
2012-05-29 |
주식회사 삼양제넥스바이오 |
고순도 무수결정형 도세탁셀 제조방법
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前-乳劑調配物及其製造與使用之方法
|
CN102970990A
(zh)
*
|
2010-05-03 |
2013-03-13 |
帝国制药美国公司 |
非水性紫杉烷前-乳剂制剂以及制备和使用该制剂的方法
|
WO2012160568A1
(en)
|
2011-05-23 |
2012-11-29 |
Shilpa Medicare Limited |
Process for preparing docetaxel trihydrate polymorph
|
JO3685B1
(ar)
*
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|